Consequences of the EU IVDR implementation for medical laboratories
Authors:
F. Spitzenberger 1,2
Authors‘ workplace:
Centre for Regulatory Affairs in Biomedical Sciences, Technische Hochschule Lübeck, Mönkhofer Weg 239, 23562 Lübeck, Germany
1; Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE, Mönkhofer Weg 239 a, 23562 Lübeck, Germany
2
Published in:
Klin. Biochem. Metab., 32, 2024, No. 1, p. 4-6
Category:
Review articles
doi:
https://doi.org/10.61568/kbm.2024.002
Overview
With the entry into force of the European Regulation (EU) 2017745 (“IVDR”) on May 26th 2022, drastic changes have occurred for practically all stakeholders in the field of in vitro diagnostic medical devices (IVD) [1]...
Labels
Clinical biochemistry Nuclear medicine Nutritive therapistArticle was published in
Clinical Biochemistry and Metabolism
2024 Issue 1
Most read in this issue
- BIOLAB 2024
- Consequences of the EU IVDR implementation for medical laboratories
- Application of biological variables in programmes of external quality assessment
- Cultivating the calculation of clinical biochemistry analyte measurement uncertainties using biological variation and internal quality control